Total liabilities · 2011–2025
Novavax total liabilities
$1.3B−40.3% · FY2025
Novavax (NVAX) reported $1.3B in total liabilities for fiscal 2025, −40.3% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.3B | −40.3% | Open → |
| FY20242024-12-31 | $2.2B | −13.1% | Open → |
| FY20232023-12-31 | $2.5B | −13.1% | Open → |
| FY20222022-12-31 | $2.9B | −1.2% | Open → |
| FY20212021-12-31 | $2.9B | +206.6% | Open → |
| FY20202020-12-31 | $955M | +166.1% | Open → |
| FY20192019-12-31 | $359M | −4.5% | Open → |
| FY20182018-12-31 | $376M | −7.0% | Open → |
| FY20172017-12-31 | $404M | +1.1% | Open → |
| FY20162016-12-31 | $400M | +328.2% | Open → |
| FY20152015-12-31 | $93.4M | +101.3% | Open → |
| FY20142014-12-31 | $46.4M | +45.4% | Open → |
| FY20132013-12-31 | $31.9M | +44.3% | Open → |
| FY20122012-12-31 | $22.1M | +73.7% | Open → |
| FY20112011-12-31 | $12.7M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +39.2%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novavax total liabilities |url=https://companiesranked.com/en/company/novavax/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novavax total liabilities. CompaniesRanked. https://companiesranked.com/en/company/novavax/total-liabilitiesBibTeX
@misc{companiesranked-en-company-novavax-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Novavax total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novavax/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001000694-26-000018 · August 6, 2026
{{cite web |title=Novavax total liabilities — 10-Q (0001000694-26-000018) |url=https://www.sec.gov/Archives/edgar/data/1000694/000100069426000018/nvax-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.